<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>NANOG is a stem cell transcription factor that is essential for embryonic development, reprogramming <z:mpath ids='MPATH_458'>normal</z:mpath> adult cells and <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> and progression </plain></SENT>
<SENT sid="1" pm="."><plain>The nearly identical retrogene NANOGP8 is expressed in <z:e sem="disease" ids="C0346429" disease_type="Neoplastic Process" abbrv="">multiple cancers</z:e>, but generally not in <z:mpath ids='MPATH_458'>normal</z:mpath> tissues and its function is not well defined </plain></SENT>
<SENT sid="2" pm="."><plain>Our postulate is that NANOGP8 directly modulates the stemness of individual human colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells </plain></SENT>
<SENT sid="3" pm="."><plain>Stemness was measured in vitro as the spherogenicity of single <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells in serum-free medium and the size of the side population (SP) and in vivo as tumorigenicity and experimental metastatic potential in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>/<z:mp ids='MP_0002536'>SCID</z:mp> mice </plain></SENT>
<SENT sid="4" pm="."><plain>We found that 80% of clinical <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> express a NANOG with 75% of the positive <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> containing NANOGP8 transcripts </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo>, 3-62% of single cells within six <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> lines form spheroids in serum-free medium in suspension </plain></SENT>
<SENT sid="6" pm="."><plain>NANOGP8 is translated into protein </plain></SENT>
<SENT sid="7" pm="."><plain>The relative expression of a NANOG gene increased 8- to 122-fold during spheroid formation, more than the increase in OCT4 or SOX2 transcripts with NANOGP8 the more prevalent family member </plain></SENT>
<SENT sid="8" pm="."><plain>Short hairpin <z:chebi fb="40" ids="33697">RNA</z:chebi> (shRNA) to NANOG not only inhibits spherogenicity but also reduces expression of OCT4 and SOX2, the size of the SP and <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in vivo </plain></SENT>
<SENT sid="9" pm="."><plain>Inhibition of NANOG gene expression is associated with inhibition of proliferation and decreased phosphorylation of G2-related cell-cycle proteins </plain></SENT>
<SENT sid="10" pm="."><plain>Overexpression of NANOGP8 rescues single-cell spherogenicity when NANOG gene expression is inhibited and increases the SP in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, NANOGP8 can substitute for NANOG in directly promoting stemness in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>.Oncogene advance online publication, 22 October 2012; doi:10.1038/onc.2012.461 </plain></SENT>
</text></document>